Brad Sleebs - Identification of 3-aminothieno[2,3b]pyridine-2-carboxamides and 4-aminobenzothieno[3,2-d]pyrimidines as LIMK1 Inhibitors

Document created by Brad Sleebs on Aug 22, 2014
Version 1Show Document
  • View in full screen mode

  Publication Details (including relevant citation   information):

  Medicinal   Chemistry Communications (2011),   2,   977-981

  Abstract:

  A high throughput chemical screening campaign has led to the   identification of   3-aminobenzo[b]thiophene-2-carboxamides as LIMK1   inhibitors. Evolution of bicyclic hits to the tricyclic   4-aminobenzothieno[3,2-d]pyrimidine, using a traditional   medicinal chemistry SAR guided approach, resulted in a   significant increase in potency. Further elaboration has seen the   7-phenyl-4-aminobenzothieno[3,2-d]pyrimidine emerge as a   LIMK1 inhibitor lead candidate.

  Address (URL):

 

Attachments

    Outcomes